Zydus Lifesciences (BOM:532321) Other Operating Expense : ₹82,541 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences Other Operating Expense?

Zydus Lifesciences's Other Operating Expense for the three months ended in Mar. 2024 was ₹23,350 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹82,541 Mil.

Zydus Lifesciences's quarterly Other Operating Expense increased from Sep. 2023 (₹19,051 Mil) to Dec. 2023 (₹19,882 Mil) and increased from Dec. 2023 (₹19,882 Mil) to Mar. 2024 (₹23,350 Mil).

Zydus Lifesciences's annual Other Operating Expense increased from Mar. 2022 (₹46,160 Mil) to Mar. 2023 (₹54,390 Mil) and increased from Mar. 2023 (₹54,390 Mil) to Mar. 2024 (₹82,541 Mil).

Zydus Lifesciences Other Operating Expense Historical Data

The historical data trend for Zydus Lifesciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences Other Operating Expense Chart

Zydus Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

46,194.00

43,793.00

46,160.00

54,390.00

82,541.00

Zydus Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															20,211.00	20,258.00	19,051.00	19,882.00	23,350.00

Zydus Lifesciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹82,541 Mil.

Zydus Lifesciences Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zydus Lifesciences (BOM:532321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » Other Operating Expense

Traded in Other Exchanges

ZYDUSLIFE:India

Address

Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481

Website

https://www.zyduslife.com

Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines